Skip to content

End-stage liver disease is a concern for people with HIV and hepatitis B or C co-infection

Ritonavir concentrations not correlated with lipid levels in people with HIV taking boosted atazanavir or boosted darunavir

Cannabis use reduces risk of insulin resistance in people with HIV/HCV co-infection

Chinese study sheds light on how well treatment may work as prevention in the real world

HCV sexual transmission linked to anal sex, drug use, lower CD4 count

Most HIV-positive gay men in European survey are on HIV treatment, though fewer in the east

More people in the UK are starting HIV treatment early, in order to reduce their risk of transmission

Adherence support improves ART outcomes in Kenya

Early antiretroviral treatment reduces, but does not eliminate HIV reservoir

Jonathan Li presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com